Crossmark

The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence

Crossref DOI link: https://doi.org/10.1038/tp.2015.68

Published Online: 2015-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suchankova, P

Yan, J

Schwandt, M L

Stangl, B L

Caparelli, E C

Momenan, R

Jerlhag, E

Engel, J A

Hodgkinson, C A

Egli, M

Lopez, M F

Becker, H C

Goldman, D

Heilig, M

Ramchandani, V A

Leggio, L
License Information

Text and Data Mining valid from 2015-06-16

Version of Record valid from 2015-06-16
More Information

Article History

Received: 8 February 2015

Revised: 18 March 2015

Accepted: 6 April 2015

First Online: 16 June 2015

Competing interests

: EJ has received financial support from the Novo Nordisk Foundation. JAE has received financial support as consultant from Pfizer and Lundbeck. The other authors, PS, JY, MLS, BLS, ECC, RM, CAH, ME, MFL, HCB, DG, MH, VAR and LL report no financial relationships with commercial interests.

Document is current

Any future updates will be listed below